Application of acute stroke imaging: Selecting patients for revascularization therapy

Neurology

Volumn 79, Issue 13 SUPPL. 1, 2012, Pages

  Shang, Tiesong ^a   Yavagal, Dileep R ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; CONTRAST MEDIUM;

ARTICLE; CEREBRAL REVASCULARIZATION; CEREBROVASCULAR ACCIDENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; PRIORITY JOURNAL; BRAIN INFARCTION; CLINICAL PROTOCOL; DIFFUSION WEIGHTED IMAGING; FIBRINOLYTIC THERAPY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT;

EID: 84867520165     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182695800     Document Type: Article

References (42)

1. NINDS Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
2. Hacke W, Kaste M, Bluhmki E, et al.; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-1329.
3. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial: Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-2011.
4. Ogawa A, Mori E, Minematsu K, et al.; MELT Japan Study Group. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan. Stroke 2007;38:2633-2639.
5. IMS Trial Investigators. Combined intravenous and intraarterial recanalization for acute ischemic stroke: the interventional management of stroke study. Stroke 2004;35:904-911.
6. IMS II Trial Investigators. The International Management of Stroke (IMS) II Study. Stroke 2007;38:2127-2135.
7. Smith WS, Sung G, Starkman S, et al.; for the MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI Trial. Stroke 2005;36:1432-1438.
8. Smith WS, Sung G, Saver J, et al., for the Multi MERCI investigators. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI Trial. Stroke 2008;39:1205-1212.
9. The Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761-2768.
10. Assess the Penumbra System in the Treatment of Acute Stroke (THERAPY). Available at: clinicaltrials.gov/ct2/show/NCT01429350?term= Therapy+trial&recr=Open&rslt=Without&type=Intr&cond= Stroke&intr=Penumbra&rank=1.
11. Riedel CH, Zimmermann P, Jensen-Kondering U, Stingele R, Deuschl G, Jansen O. The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke 2011;42:1775-1777.
12. Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke 1981;12:723-725.
13. Astrup J, Symon L, Branston NM, Lassen NA. Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia. Stroke 1977;8:51-57.
14. Chemmanam T, Campbell BC, Christensen S, et al; EPITHET Investigators. Ischemic diffusion lesion reversal is uncommon and rarely alters perfusiondiffusion mismatch. Neurology 2010;75:1040-1047.
15. Jovin TG, Yonas H, Gebel JM, et al. The cortical ischemic core and not the consistently present penumbra is a determinant of clinical outcome in acute middle cerebral artery occlusion. Stroke 2003;34:2426-2433.
16. Heidenreich JO, Hsu D, Wang G, et al. Magnetic resonance imaging results can affect therapy decisions in hyperacute stroke care. Acta Radiol 2008;49:550-557.
17. Wechsler LR. Imaging evaluation of acute ischemic stroke. Stroke 2011;42:S12-S15.
18. Bandera E, Botteri M, Minelli C, Sutton A, Abrams KR, Latronico N. Cerebral blood flow threshold of ischemic penumbra and infarct core in acute ischemic stroke: a systematic review. Stroke 2006;37:1334-1339.
19. Murphy BD, Fox AJ, Lee DH, et al. Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurements. Stroke 2006;37:1771-1777.
20. Schaefer PW, Barak ER, Kamalian S, et al. Quantitative assessment of core/penumbra mismatch in acute stroke: CT and MR perfusion imaging are strongly correlated when sufficient brain volume is imaged. Stroke 2008;39:2986-2992.
21. Jovin TG, Liebeskind DS, Gupta R, et al. Imaging-based endovascular therapy for acute ischemic stroke due to proximal intracranial anterior circulation occlusion treated beyond 8 hours from time last seen well: retrospective multicenter analysis of 237 consecutive patients. Stroke 2011;42:2206-2211.
22. Axel L. Cerebral blood flow determination by rapidsequence computed tomography: theoretical analysis. Radiology 1980;137:679-686.
23. Konstas AA, Goldmakher GV, Lee TY, Lev MH. Theoretic basis and technical implementations of CT perfusion in acute ischemic stroke, part 1: theoretic basis. AJNR Am J Neuroradiol 2009;30:662-668.
24. Lev MH, Segal AZ, Farkas J, et al. Utility of perfusionweighted CT imaging in acute middle cerebral artery stroke treated with intra-arterial thrombolysis: prediction of final infarct volume and clinical outcome. Stroke 2001;32:2021-2028.
25. Wintermark M, Reichhart M, Thiran JP, et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol 2002;51:417-432.
26. Rai AT, Raghuram K, Domico J, Hobbs G, Carpenter J. Pre-intervention triage incorporating perfusion imaging improves outcomes in patients undergoing endovascular stroke therapy: a comparison with the device trials. J Neurointerv Surg Epub 2012 Feb. 18.
27. Fahmi F, Marquering HA, Streekstra GJ, et al. Differences in CT perfusion summary maps for patients with acute ischemic stroke generated by 2 software packages. AJNR Am J Neuroradiol Epub 2012 May 3.
28. Lima FO, Lev MH, Levy RA, et al. Functional contrastenhanced CT for evaluation of acute ischemic stroke does not increase the risk of contrast-induced nephropathy. AJNR Am J Neuroradiol 2010;31:817-821.
29. Mnyusiwalla A, Aviv RI, Symons SP. Radiation dose from multidetector row CT imaging for acute stroke. Neuroradiol 2009;51:635-640.
30. Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion And Perfusion Imaging Evaluation For Understanding Stroke Evolution (DEFUSE) Study. Ann Neurol 2006;60:508-517.
31. Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3h after stroke onset in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomized trial. Lancet Neurology 2008;7:299-399.
32. Hacke W, Furlan AJ, Al-Rawi Y, et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, doubleblind, placebo-controlled study. Lancet Neurol 2009;8:141-150.
33. Mishra NK, Albers GW, Davis SM, et al. Mismatch-based delayed thrombolysis: a meta-analysis. Stroke 2010;41:e25-e33.
34. Olivot JM, Mlynash M, Thijs VN, et al. Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke 2009;40:469-475.
35. Janjua N, El-Gengaihy A, Pile-Spellman J, Qureshi AI. Late endovascular revascularization in acute ischemic stroke based on clinical-diffusion mismatch. AJNR Am J Neuroradiol 2009;30:1024-1027.
36. Chernyshev OY, Martin-Schild S, Albright KC, et al. Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia. Neurology 2010;74:1340-1345.
37. Yoo AJ, Verduzco LA, Schaefer PW, Hirsch JA, Rabinov JD, González RG. MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization. Stroke 2009;40:2046-2054.
38. Mlynash M, Lansberg MG, De Silva DA, et al.; DEFUSEEPITHET Investigators. Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set. Stroke 2011;42:1270-1275.
39. Tanne D. Imaging blood-brain barrier disruption: an evolving tool for assessing the risk of hemorrhage after thrombolysis. Nat Clin Pract Neurol 2008;4:644-645.
40. *- permeability magnetic resonance imaging. Ann Neurol 2007;62:170-176.
41. Hom J, Dankbaar JW, Soares BP, et al. Blood-brain barrier permeability assessed by perfusion CT predicts symptomatic hemorrhagic transformation and malignant edema in acute ischemic stroke. AJNR Am J Neuroradiol 2011;32:41-48.
42. Pham T, Shang T, Milan D, et al. MRI turn-around time for acute stroke imaging remains unchanged over a 2 year time period. Presented at the International Stroke Conference; February 9-11, 2011; Los Angeles, CA.